Cite
HARVARD Citation
Cunningham, R. et al. (2023). YAP/TAZ activation predicts clinical outcomes in mesothelioma and is conserved in in vitro model of driver mutations. Clinical and translational medicine. 13 (2), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Cunningham, R. et al. (2023). YAP/TAZ activation predicts clinical outcomes in mesothelioma and is conserved in in vitro model of driver mutations. Clinical and translational medicine. 13 (2), p. n/a. [Online].